Searched for
RANBAXY LABS CASE
Five top challenges for Sun in Ranbaxy acquisitionUndoing of regulatory tangles in Ranbaxy may prove to be challenging for Sun Pharma’s Dilip Shangvi. Here are 5 biggest things Sun needs to...08 Apr, 2014, 01.58 AM IST- 2.3 per cent of Indian drugs found sub-standard, US doctors raise doubts on qualityThis latest set of data from the government comes amidst doubts raised by a section of American doctors and academicians over the quality o...20 Mar, 2014, 04.00 AM IST
- Ranbaxy's Toansa plant under Indian drug regulator's watch tooIndia’s drug regulator has ordered Ranbaxy to furnish a comprehensive explanation for the violation of manufacturing practices at its Toans...30 Jan, 2014, 04.00 AM IST
- Ranbaxy a lost case? Investors better off selling the stockToansa is the key active pharmaceutical ingredients facility and an alert is likely to put further pressure on business at least in the sho...25 Jan, 2014, 11.19 AM IST
- Pharma companies grapple with rise in other expensesThe other expenses of these companies rose at a much higher pace than their revenues over the last three years, says a study.07 Oct, 2013, 11.24 AM IST
- Now, drugmaker USV pulled up by USFDA for data fudgingAfter an inspection of USV's Mumbai lab, USFDA said the company's "drug product test method validation data is falsified", according to doc...23 Sep, 2013, 04.17 AM IST
- Ranbaxy Laboratories bounces back after 30% fall on MondayRanbaxy Laboratories rallied over 6%, a day after the stock plunged a little over 30% on reports that USFDA has issued an import alert.17 Sep, 2013, 10.17 AM IST
- Widespread retrenchment at Ranbaxy: 400 may be shown the door as it turns a house of troubleOn Friday, some senior executives from the Research & Development wing were given marching orders," an employee familiar with the job cuts ...06 Jul, 2013, 11.16 AM IST
- UK drug regulator reviewing Ranbaxy's regulatory issuesThe UK drug regulator is reviewing Ranbaxy regulatory issues in the light of recent revelations to see whether the situation warrants any a...29 Jun, 2013, 06.38 AM IST
- EU watchdog slaps fine on Ranbaxy for anti-competition deal over anti-depressantRanbaxy to appeal against the EU charges of delaying access to a generic version of a blockbuster anti-depressant.20 Jun, 2013, 03.46 AM IST
- No decision on Ranbaxy probe yet: Health MinistryThe Health min is still taking stock of the Ranbaxy Labs' US-related problems, but has not yet decided to launch any probe on the matter24 May, 2013, 04.01 AM IST
- Ranbaxy to pay $500 mn to US Department of Justice for settlement of felony charges related to drug safetyRanbaxy pleaded guilty to felony charges related to drug safety & will pay $500 mn in fines under settlement agreement with US Department o...14 May, 2013, 06.58 PM IST
- Ranbaxy shares dive 7% as Mylan sues USFDA over Lipitor approvalFor investors of Ranbaxy Labs, it has been a rough ride. The drugmaker has encountered a series of setbacks and its stock has been pummelle...22 Mar, 2011, 05.33 AM IST
- Ranbaxy deal will have big impact on mid-sized cosThe mega Ranbaxy deal will have a trickle-down impact on mid-sized companies Zenotech Labs and Orchid Pharma in which the Delhi-based numbe...12 Jun, 2008, 02.11 AM IST
- Generic firms & innovators tie up to cut legal costsIn these settlements, the generic company typically agrees to delay its entrance in the market in exchange for certain benefits. Lifestyle ...17 Nov, 2007, 01.25 PM IST
- Wockhardt challenges patents litigationWockhardt Pharma has just got into the game. The co is challenging Abbott Lab patent on epilepsy drug.25 May, 2007, 02.30 AM IST
- Local generic cos eye US windfallIndian generic pharma companies may now find it easier to challenge patents in the US. In another twist in the battle between innovators an...09 May, 2007, 02.13 AM IST
Load More
